San Francisco, CA, United States of America

Mary Remien


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 75(Granted Patents)


Company Filing History:

goldMedal1 out of 832,761 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Mary Remien in Analgesic Potency Enhancement

Introduction

Mary Remien is an accomplished inventor based in San Francisco, CA (US). She has made significant contributions to the field of analgesics, particularly through her innovative approaches to enhancing the potency of tramadol while minimizing its adverse side effects. Her work is crucial in improving pain management therapies.

Latest Patents

Mary Remien holds a patent for her invention titled "Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects." This invention focuses on the use of tramadol in combination with an opioid antagonist to enhance its analgesic effects while reducing negative side effects such as nausea, dizziness, and sedation. The methods involve administering tramadol alongside an effective amount of an excitatory opioid receptor antagonist, such as naltrexone or nalmefene, to achieve these benefits.

Career Highlights

Throughout her career, Mary has demonstrated a commitment to advancing medical science and improving patient outcomes. Her innovative patent reflects her dedication to addressing the challenges associated with pain management. With a total of 1 patent, her work stands out in the field of pharmacology.

Collaborations

Mary has collaborated with notable professionals in her field, including Stanley M Crain and Ke-fei Shen. These partnerships have likely contributed to the depth and impact of her research and inventions.

Conclusion

Mary Remien's contributions to the field of analgesics through her innovative patent highlight her role as a significant inventor. Her work not only enhances the effectiveness of tramadol but also aims to improve the quality of life for patients experiencing pain.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…